FindTrial
Sign In

Additive effect of Tiotropium on Fluticasone propionate /Formoterol in elderly patients with asthma

Additive effect of Tiotropium on Fluticasone propionate /Formoterol in elderly patients with asthma - Additive effect of Tiotropium on Fluticasone propionate /Formoterol in elderly patients with asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000039092
Enrollment
30
Registered
2025-03-31
Start date
2018-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Additive effect of Tiotropium on Fluticasone propionate /Formoterol in elderly patients with asthma

Interventions

Additional treatment of Tiotropium on Fluticasone propionate /Formoterol

Sponsors

Kansai Medical University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Elderly patients with bronchial asthma

Exclusion criteria

Exclusion criteria: 1) Patients with unstable symptoms 2) Patients needed hospitalization because of infectious diseases 3) Patients with hospitalization within 8 weeks 4) Patients with severe hepatic or renal disease 5) Patients with uncontrolled diabes mellitus 6) Female with pregnancy 7) Female breast-feeding baby 8) Patients enrolled by clinical trials within 3 month 9) Patients recognized as insufficient

Design outcomes

Primary

MeasureTime frame
Changes of forced expiriratory volume in one second, a respiratory function test.—

Countries

Japan

Contacts

Public ContactYoshihisa Ishiura

Kansai Medical University Medical Center Division of Respiratory, Oncology and Allergy

ishiuray@takii.kmu.ac.jp0669921001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026